CAR-T therapy is a highly specialized treatment that requires careful patient selection and close monitoring. Some patients ...

After a median follow-up of 10 years, more than one-third of patients with large B-cell lymphoma and nearly half of patients ...

Leading CAR T cell therapy researchers have developed a human-in-the-loop artificial intelligence (AI) framework that centers ...

At its latest R&D update, Moderna revealed a move into the pioneering in vivo CAR-T category, adding another treatment class ...

For the 18 million people living with rheumatoid arthritis, disease management currently means a lifetime of injections-a ...

Researchers at Weill Cornell Medicine, Cedars-Sinai Medical Center and Roswell Park Comprehensive Cancer Center have ...

Angus reports on the basic research, clinical science, and drug development that may transform survival and quality of life for patients, as well as developments affecting the cancer community. You ...

CAR-T cell therapy is already a potent treatment for certain cancers. Now, a small study is showing early promise for managing HIV. A Miracle cancer therapy that involves engineering a patient’s own ...

Landau, MD, discussed promising results of CAR T-cell therapy in light chain amyloidosis and the challenge of developing ...

Chimeric antigen receptor (CAR) T-cell (CAR T) therapies have revolutionized the care of patients with multiple myeloma (MM) 1. Recently, the first two B cell maturation antigen (BCMA)-targeted CAR T ...

The world's first CAR-T cell therapy targeting solid tumors, developed by a Shanghai-based biopharmaceutical company, has ...

Researchers have discovered that some CAR-T cells engineered to fight cancer and other conditions carry the memory of past encounters with bacteria, viruses and other antigens within them, a finding ...